Literature DB >> 16809269

Long-term graft and patient survival following renal transplantation in diabetic patients.

Vibeke Rømming Sørensen1, Søren Schwartz Sørensen, Bo Feldt-Rasmussen.   

Abstract

OBJECTIVE: To study long-term graft and patient survival following renal transplantation in diabetic and non-diabetic patients.
MATERIAL AND METHODS: Over the time period 1985-99, 498 transplantations in 399 non-diabetic patients and 68 transplantations in 62 diabetic patients were performed. The groups were similar with respect to age and sex.
RESULTS: The patient survival rates (diabetic versus non-diabetic patients) were 88% vs 91% (p=NS) at 1 year, 68% vs 73% (p=NS) at 5 years and 31% vs 52% (p<0.05) at 10 years. The graft survival rates (diabetic versus non-diabetic patients) were 72% vs 72% at 1 year, 52% vs 52% at 5 years and 27% vs 33% (p=NS) at 10 years. In the diabetic patients, mean haemoglobin (Hb)A1c 2 years before and 2 years after the transplantation was 7.5+/-1.4 vs 8.2+/-1.6 mmol/l (p<0.05) and the mean blood pressure was 112+/-12 vs 107+/-9 mmHg (p<0.05). Of the diabetic patients, 55% were smokers. Among the diabetic patients, graft and patient survival were independent of smoking habits, blood pressure, HbA1c and total cholesterol.
CONCLUSIONS: Graft survival was similar in diabetic and non-diabetic patients. For the first 5 years following renal transplantation, the patient survival rates in the two groups were similar. Thereafter, survival among diabetic patients was poor. Mean HbA1c was relatively high, especially after the transplantation, and this may have contributed to the more rapid progression of cardiovascular disease seen in diabetic patients with nephropathy.

Entities:  

Mesh:

Year:  2006        PMID: 16809269     DOI: 10.1080/00365590600620792

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  2 in total

1.  Improved survival rate in patients with diabetes and end-stage renal disease in Denmark.

Authors:  V R Sørensen; E R Mathiesen; J Heaf; B Feldt-Rasmussen
Journal:  Diabetologia       Date:  2007-02-28       Impact factor: 10.122

2.  Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials.

Authors:  Claudia Sommerer; Oliver Witzke; Frank Lehner; Wolfgang Arns; Petra Reinke; Ute Eisenberger; Bruno Vogt; Katharina Heller; Johannes Jacobi; Markus Guba; Rolf Stahl; Ingeborg A Hauser; Volker Kliem; Rudolf P Wüthrich; Anja Mühlfeld; Barbara Suwelack; Michael Duerr; Eva-Maria Paulus; Martin Zeier; Martina Porstner; Klemens Budde
Journal:  BMC Nephrol       Date:  2018-09-19       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.